spacer
home > ebr > summer 2003 > spr-ms in functional proteomics
PUBLICATIONS
European Biopharmaceutical Review

SPR-MS in Functional Proteomics

As the advent of proteomics switches the emphasis from genes to proteins, increased scientific attention is being paid to techniques that produce detailed information on human proteins. Much interest has been concentrated on identification and structural characterisation of the proteins in a cell, using techniques such as mass spectrometry (MS). The true value of genomic information however, will only be realised when this data is combined with functional characterisation of the proteins in question, using techniques such as surface plasmon resonance (SPR). It is not often that two analytical techniques can be successfully combined to correlate data, whilst simultaneously increasing the quality and quantity of output - but this is the case with SPR and MS.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Dr Stefan Löfås, Vice President and Chief Scientific Officer at Biacore AB

Dr Stefan Löfås holds a PhD and BSc in Organic Chemistry. He has gained extensive technical and scientific experience in the development and commercialisation of bioanalytical instrumentation at Biacore AB, having worked for the company since 1985. He has been deeply involved in the development of Biacore's sensor chip chemistry and applications. He was recently appointed Chief Scientific Officer with responsibility for technical development projects, external scientific collaborations and technical aspects on IPR portfolio. Prior to this, Dr Löfås was Director of Biacore's biochemistry & chemistry department within R&D.

spacer
Dr Stefan Löfås
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

MedPharm accelerates strategy to broaden service offering into commercial manufacturing

MedPharm Ltd, a leading contract provider of topical and transdermal product design and development services, has announced two new appointments to its Board to support plans to grow its commercial manufacturing services.
More info >>

White Papers

Life Cycle of an Analytical Method - a Case Study on the Monocyte Activation Test

Wickham Laboratories Limited

Pyrogens, a heterogeneous group of fever inducing contaminants, are comprised of microbial and non-microbial compounds; e.g. endotoxin (lipopolysaccharide, LPS) produced by Gram-negative bacteria, lipoteichoic acid (LTA) from Gram-positive bacteria, bacterial DNA (CpG-motive), endogenous pyrogens, virus and fungi particles or even fragments of packaging materials, plastic and dust. Contaminat ion wi th pyrogens in pharmaceutical products, biotherapeutics and on medical devices can lead to life threatening fever reactions. To ensure consumer safety, pyrogen testing is mandatory for parenteral products and medical devices.
More info >>

 
Industry Events

DIA 2019 Global Annual Meeting

23-27 June 2019, San Diego Convention Center

DIA 2019 is more than just a meeting: it’s where brilliant minds come together to create solutions. Thousands of global innovators will convene to engage in discussions on today’s hottest topics in the life sciences field, propose ways to combat daily challenges, and network to create lasting connections.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement